GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Akciju saraksts・Camurus AB

Camurus AB

Slēgts

723.5 -0.07

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

716

Max

730

Galvenie mērījumi
By Trading Economics
Ienākumi	53M 292M
Pārdošana	117M 676M
P/E Sektora vidējais	59.883 35.733
EPS	4.08
Peļņas marža	43.235
Darbinieki	267
EBITDA	54M 315M

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	1.8B 43B
Iepriekšējā atvēršanas cena	723.57
Iepriekšējā slēgšanas cena	723.5

Camurus AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 5. sept. 16:09 UTC

Iegādes, apvienošanās, pārņemšana

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

2025. g. 5. sept. 20:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 5. sept. 20:37 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

2025. g. 5. sept. 20:37 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

2025. g. 5. sept. 20:36 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

2025. g. 5. sept. 20:36 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

2025. g. 5. sept. 20:33 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

2025. g. 5. sept. 20:33 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

2025. g. 5. sept. 20:31 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

2025. g. 5. sept. 20:20 UTC

Peļņas

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 19:23 UTC

Tirgus saruna

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

2025. g. 5. sept. 19:22 UTC

Peļņas

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

2025. g. 5. sept. 19:17 UTC

Tirgus saruna

U.S. Natural Gas Snaps Winning Streak -- Market Talk

2025. g. 5. sept. 18:59 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 18:35 UTC

Tirgus saruna

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

2025. g. 5. sept. 17:25 UTC

Tirgus saruna

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

2025. g. 5. sept. 17:20 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

2025. g. 5. sept. 17:17 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 5. sept. 17:17 UTC

Tirgus saruna

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

2025. g. 5. sept. 17:03 UTC

Tirgus saruna

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Energy Roundup: Market Talk

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

2025. g. 5. sept. 16:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 5. sept. 16:16 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Camurus AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Camurus AB

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain and Brixadi to treat opioid use disorder. Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; and Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity, as well as licensing agreement with Solasia Pharma. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.